Clinical Efficacy and Safety of Mesenchymal Stem Cell Transplantation for Osteoarthritis Treatment: A Meta-analysis

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2017 Apr 28

PMID 28448518

Citations 68

Authors

Ma Yubo

Li Yanyan

Li Li

Sun Tao

Lin Bo

Chen Lin

Affiliations

Soon will be listed here.

Abstract

Purpose: The aim of this study was to evaluate the therapeutic efficacy and safety of mesenchymal stem cells (MSCs) for the treatment of patients with knee osteoarthritis (OA).

Materials: We performed a meta-analysis of relevant published clinical studies. An electronic search was conducted for randomized controlled trials (RCTs) of MSC-based therapy in knee OA. The visual analogue scale (VAS), International Knee Documentation Committee (IKDC) form, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Lequesne algofunctional indices (Lequesne), Lysholm knee scale (Lysholm), Tegner activity scale (Tegner) and adverse events (AEs) were evaluated.

Results: Eleven eligible trials with 582 knee OA patients were included in the present meta-analysis. We demonstrated that MSC treatment could significantly decrease VAS and increase IKDC scoresafter a 24-month follow-up compared with controls (P<0.05). MSC therapy also showed significant decreases in WOMAC and Lequesne scores after the 12-month follow-up (P<0.01). Analysis of Lysholm (24-month) and Tegner (12- and 24-month) scores also demonstrated favorable results for MSC treatment (P<0.05).

Conclusion: Overall, MSC transplantation treatment was shown to be safe and has great potential as an efficacious clinical therapy for patients with knee OA.

Citing Articles

Mesenchymal stem cells therapy for the treatment of non-union fractures: a systematic review and meta-analysis.

Cui C, Lin F, Xia L, Zhang X BMC Musculoskelet Disord. 2025; 26(1):245.

PMID: 40069694 PMC: 11900535. DOI: 10.1186/s12891-025-08365-w.

Advanced therapy with mesenchymal stromal cells for knee osteoarthritis: Systematic review and meta-analysis of randomized controlled trials.

Tabet C, Pacheco R, Martimbianco A, Riera R, Hernandez A, Bueno D J Orthop Translat. 2024; 48:176-189.

PMID: 39360004 PMC: 11445595. DOI: 10.1016/j.jot.2024.07.012.

Mesenchymal Stem Cell-Derived Exosomes as a Treatment Option for Osteoarthritis.

Vadhan A, Gupta T, Hsu W Int J Mol Sci. 2024; 25(17).

PMID: 39273098 PMC: 11395657. DOI: 10.3390/ijms25179149.

The tardigrade-derived mitochondrial abundant heat soluble protein improves adipose-derived stem cell survival against representative stressors.

Rolsma J, Darch W, Higgins N, Morgan J Sci Rep. 2024; 14(1):11834.

PMID: 38783150 PMC: 11116449. DOI: 10.1038/s41598-024-62693-w.

Adipose-derived regenerative therapies for the treatment of knee osteoarthritis.

Epanomeritakis I, Khan W World J Stem Cells. 2024; 16(4):324-333.

PMID: 38690511 PMC: 11056639. DOI: 10.4252/wjsc.v16.i4.324.

References

McCorry M, Puetzer J, Bonassar L . Characterization of mesenchymal stem cells and fibrochondrocytes in three-dimensional co-culture: analysis of cell shape, matrix production, and mechanical performance. Stem Cell Res Ther. 2016; 7:39. PMC: 4789279. DOI: 10.1186/s13287-016-0301-8. View

Smith B, Sigal I, Grande D . Immunology and cartilage regeneration. Immunol Res. 2015; 63(1-3):181-6. DOI: 10.1007/s12026-015-8720-7. View

Morille M, Toupet K, Montero-Menei C, Jorgensen C, Noel D . PLGA-based microcarriers induce mesenchymal stem cell chondrogenesis and stimulate cartilage repair in osteoarthritis. Biomaterials. 2016; 88:60-9. DOI: 10.1016/j.biomaterials.2016.02.022. View

Greene M, Loeser R . Aging-related inflammation in osteoarthritis. Osteoarthritis Cartilage. 2015; 23(11):1966-71. PMC: 4630808. DOI: 10.1016/j.joca.2015.01.008. View

Chen W, Lo W, Hsu W, Wei H, Liu H, Lee C . Synergistic anabolic actions of hyaluronic acid and platelet-rich plasma on cartilage regeneration in osteoarthritis therapy. Biomaterials. 2014; 35(36):9599-607. DOI: 10.1016/j.biomaterials.2014.07.058. View

Nyvang J, Hedstrom M, Andreassen Gleissman S . It's not just a knee, but a whole life: A qualitative descriptive study on patients' experiences of living with knee osteoarthritis and their expectations for knee arthroplasty. Int J Qual Stud Health Well-being. 2016; 11:30193. PMC: 4818353. DOI: 10.3402/qhw.v11.30193. View

Kessler M, Ackerman G, Dines J, Grande D . Emerging technologies and fourth generation issues in cartilage repair. Sports Med Arthrosc Rev. 2008; 16(4):246-54. DOI: 10.1097/JSA.0b013e31818d56b3. View

Reissis D, Tang Q, Cooper N, Carasco C, Gamie Z, Mantalaris A . Current clinical evidence for the use of mesenchymal stem cells in articular cartilage repair. Expert Opin Biol Ther. 2016; 16(4):535-57. DOI: 10.1517/14712598.2016.1145651. View

Vangsness Jr C, Farr 2nd J, Boyd J, Dellaero D, Mills C, LeRoux-Williams M . Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. J Bone Joint Surg Am. 2014; 96(2):90-8. DOI: 10.2106/JBJS.M.00058. View

10.

Mizuno K, Muneta T, Morito T, Ichinose S, Koga H, Nimura A . Exogenous synovial stem cells adhere to defect of meniscus and differentiate into cartilage cells. J Med Dent Sci. 2009; 55(1):101-11. View

11.

Edd S, Giori N, Andriacchi T . The role of inflammation in the initiation of osteoarthritis after meniscal damage. J Biomech. 2015; 48(8):1420-6. DOI: 10.1016/j.jbiomech.2015.02.035. View

12.

Musumeci G, Castrogiovanni P, Leonardi R, Trovato F, Szychlinska M, Di Giunta A . New perspectives for articular cartilage repair treatment through tissue engineering: A contemporary review. World J Orthop. 2014; 5(2):80-8. PMC: 4017310. DOI: 10.5312/wjo.v5.i2.80. View

13.

Centeno C, Pitts J, Al-Sayegh H, Freeman M . Efficacy of autologous bone marrow concentrate for knee osteoarthritis with and without adipose graft. Biomed Res Int. 2014; 2014:370621. PMC: 4170694. DOI: 10.1155/2014/370621. View

14.

Akgun I, Unlu M, Erdal O, Ogut T, Erturk M, Ovali E . Matrix-induced autologous mesenchymal stem cell implantation versus matrix-induced autologous chondrocyte implantation in the treatment of chondral defects of the knee: a 2-year randomized study. Arch Orthop Trauma Surg. 2014; 135(2):251-263. DOI: 10.1007/s00402-014-2136-z. View

15.

Schu S, Nosov M, OFlynn L, Shaw G, Treacy O, Barry F . Immunogenicity of allogeneic mesenchymal stem cells. J Cell Mol Med. 2011; 16(9):2094-103. PMC: 3822979. DOI: 10.1111/j.1582-4934.2011.01509.x. View

16.

Murrell W, Anz A, Badsha H, Bennett W, Boykin R, Caplan A . Regenerative treatments to enhance orthopedic surgical outcome. PM R. 2015; 7(4 Suppl):S41-S52. DOI: 10.1016/j.pmrj.2015.01.015. View

17.

Zellner J, Hierl K, Mueller M, Pfeifer C, Berner A, Dienstknecht T . Stem cell-based tissue-engineering for treatment of meniscal tears in the avascular zone. J Biomed Mater Res B Appl Biomater. 2013; 101(7):1133-42. DOI: 10.1002/jbm.b.32922. View

18.

Koh Y, Choi Y . Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee. 2012; 19(6):902-7. DOI: 10.1016/j.knee.2012.04.001. View

19.

Peeters C, Leijs M, Reijman M, van Osch G, Bos P . Safety of intra-articular cell-therapy with culture-expanded stem cells in humans: a systematic literature review. Osteoarthritis Cartilage. 2013; 21(10):1465-73. DOI: 10.1016/j.joca.2013.06.025. View

20.

Nejadnik H, Hui J, Feng Choong E, Tai B, Lee E . Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med. 2010; 38(6):1110-6. DOI: 10.1177/0363546509359067. View